Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Carboplatin in Advanced TNBC
NCT02531932Phase 2Completed
- Sponsor
- Amy Tiersten
- Start
- Dec 2015
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in triple-negative breast cancer (TNBC), sponsored by Amy Tiersten. Started Dec 2015; status: completed.
02
Drugs
everolimus
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02531932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531932.